ArticlePloS one2026
Sex differences in early and late neonatal all-cause mortality and disease burden in Kazakhstan, 2010-2023: A population-based analysis of Global Burden of Disease estimates.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNeonatal mortality remains a major contributor to child mortality globally, with the greatest burden concentrated in the early neonatal period. Sex differences in neonatal survival are consistently reported, yet population-level evidence on sex-specific patterns of all-cause burden across neonatal subperiods in Central Asia remains limited. This study aimed to quantify temporal trends and sex differences in early (0-6 days) and late (7-27 days) neonatal all-cause mortality and disease burden in Kazakhstan from 2010 to 2023, and to examine projected trajectories to 2030.
methodsWe conducted a population-based time-trend study using Global Burden of Disease 2023 estimates for Kazakhstan. Outcomes included mortality, disability-adjusted life years (DALYs), years of life lost (YLLs), and years lived with disability (YLDs), expressed as age-specific rates per 100,000 person-years within the corresponding neonatal age interval. Analyses were stratified by sex and neonatal subperiod. Temporal patterns were described, and sex differences were assessed using comparative rates. Log-linear models were used to estimate projected trends to 2030. National mortality statistics were used for external trend consistency.
resultsNeonatal mortality and DALY rates declined between 2010 and 2023 in both early and late neonatal periods, with substantially higher rates observed in the early neonatal period. Across all years, males consistently exhibited higher mortality, YLLs, and DALYs than females in both neonatal subperiods; YLD rates followed a different pattern, being modestly higher among females in the early-neonatal period but nearly equal between sexes in the late-neonatal period. YLLs accounted for the vast majority of DALYs, indicating that mortality rather than non-fatal disability drives neonatal burden. Projections suggest continued declines through 2030, male point estimates for mortality and DALYs remained higher than female estimates throughout, although the magnitude of this difference narrowed substantially and became statistically uncertain in the most recent years, with rate-ratio uncertainty intervals spanning or approaching unity.
conclusionsDespite substantial reductions in neonatal mortality in Kazakhstan, male point estimates for mortality and burden remained higher than female estimates throughout the study period, although this difference narrowed substantially and became uncertain in recent years; mortality remained heavily concentrated in the early neonatal period. These findings highlight persistent, though narrowing, epidemiologic inequalities within improving population health trends.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.